These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 24999533)
21. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135 [TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64. Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913 [TBL] [Abstract][Full Text] [Related]
23. Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT. Hoffmann SHL; Maurer A; Reck DI; Reischl G; Pichler BJ; Kneilling M; Griessinger CM J Vis Exp; 2017 Apr; (122):. PubMed ID: 28518105 [TBL] [Abstract][Full Text] [Related]
24. Cu Han J; Wang X; Yu M Bioorg Med Chem Lett; 2016 Nov; 26(22):5594-5596. PubMed ID: 27780640 [TBL] [Abstract][Full Text] [Related]
25. Copper chelation chemistry and its role in copper radiopharmaceuticals. Wadas TJ; Wong EH; Weisman GR; Anderson CJ Curr Pharm Des; 2007; 13(1):3-16. PubMed ID: 17266585 [TBL] [Abstract][Full Text] [Related]
26. Remote-loading of liposomes with manganese-52 and in vivo evaluation of the stabilities of Jensen AI; Severin GW; Hansen AE; Fliedner FP; Eliasen R; Parhamifar L; Kjær A; Andresen TL; Henriksen JR J Control Release; 2018 Jan; 269():100-109. PubMed ID: 29122662 [TBL] [Abstract][Full Text] [Related]
28. New bifunctional chelator for 64Cu-immuno-positron emission tomography. Pandya DN; Bhatt N; Dale AV; Kim JY; Lee H; Ha YS; Lee JE; An GI; Yoo J Bioconjug Chem; 2013 Aug; 24(8):1356-66. PubMed ID: 23883075 [TBL] [Abstract][Full Text] [Related]
29. Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals. Cai Z; Anderson CJ J Labelled Comp Radiopharm; 2014 Apr; 57(4):224-30. PubMed ID: 24347474 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator. Wei L; Butcher C; Miao Y; Gallazzi F; Quinn TP; Welch MJ; Lewis JS J Nucl Med; 2007 Jan; 48(1):64-72. PubMed ID: 17204700 [TBL] [Abstract][Full Text] [Related]
31. Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide. Huang CW; Li Z; Cai H; Shahinian T; Conti PS Bioconjug Chem; 2011 Feb; 22(2):256-63. PubMed ID: 21244039 [TBL] [Abstract][Full Text] [Related]
32. Click-chemistry strategy for labeling antibodies with copper-64 via a cross-bridged tetraazamacrocyclic chelator scaffold. Kumar A; Hao G; Liu L; Ramezani S; Hsieh JT; Öz OK; Sun X Bioconjug Chem; 2015 Apr; 26(4):782-9. PubMed ID: 25760776 [TBL] [Abstract][Full Text] [Related]
34. Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging. Yap ML; McFadyen JD; Wang X; Zia NA; Hohmann JD; Ziegler M; Yao Y; Pham A; Harris M; Donnelly PS; Hogarth PM; Pietersz GA; Lim B; Peter K Theranostics; 2017; 7(10):2565-2574. PubMed ID: 28819447 [No Abstract] [Full Text] [Related]
35. An approach towards molecular imaging of activated platelets allows imaging of symptomatic human carotid plaques in a new model of a tissue flow chamber. von Elverfeldt D; Meissner M; Peter K; Paul D; Meixner F; Neudorfer I; Merkle A; Harloff A; Zirlik A; Schöllhorn J; Markl M; Hennig J; Bode C; von zur Muhlen C Contrast Media Mol Imaging; 2012; 7(2):204-13. PubMed ID: 22434633 [TBL] [Abstract][Full Text] [Related]
36. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
37. Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Ta HT; Prabhu S; Leitner E; Jia F; von Elverfeldt D; Jackson KE; Heidt T; Nair AK; Pearce H; von Zur Muhlen C; Wang X; Peter K; Hagemeyer CE Circ Res; 2011 Aug; 109(4):365-73. PubMed ID: 21700932 [TBL] [Abstract][Full Text] [Related]
38. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice. Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468 [TBL] [Abstract][Full Text] [Related]
39. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. Glaus C; Rossin R; Welch MJ; Bao G Bioconjug Chem; 2010 Apr; 21(4):715-22. PubMed ID: 20353170 [TBL] [Abstract][Full Text] [Related]
40. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]